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bstract
Semliki Forest virus (SFV, Alphavirus) induce rapid shut down of host cell protein synthesis and apoptotic death of infected vertebrate cells. Data
n alphavirus-induced apoptosis are controversial. In this study, the anti-apoptotic bcl-2 gene was placed under the control of duplicated subgenomic
romoter or different internal ribosome entry sites (IRES) and expressed using a novel bicistronic SFV vector. The use of IRES containing vectors
esulted in high-level Bcl-2 synthesis during the early stages of infection. Nevertheless, in infected BHK-21 cells translational shutdown was almost
omplete by 6 h post-infection, which was similar to infection with appropriate control vectors. These results indicate that very early and high-level
cl-2 expression did not have a protective effect against SFV induced shutdown of host cell translation. No apoptotic cells were detected at those
ime points for any SFV vectors. Furthermore, Bcl-2 expression did not protect BHK-21 or AT3-neo cells at later time points, and infection of
HK-21 or AT3-neo cells with SFV replicon vectors or with wild-type SFV4 did not lead to release of cytochrome c from mitochondria. Taken
ogether, our data suggest that SFV induced death in BHK-21 or AT3-neo cells is not triggered by the intrinsic pathway of apoptosis.
2007 Elsevier B.V.
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. Introduction
Semliki Forest virus (SFV) is a positive-stranded RNA virus
n Alphavirus genus (family Togaviridae), a widely distributed
roup of human and animal pathogens (Strauss and Strauss,
994). SFV genomic RNA (so-called 42S RNA) is approxi-
ately 11.5 kb long and encodes four non-structural proteins
esignated nsP1–4; these are involved in viral RNA synthesis.
he remaining proteins form the virus capsid and envelope and
re not essential for virus replication.
After virus entry, the 42S RNA is translated into a large
on-structural polyprotein, which is processed to form an early
nd subsequently a late replicase complex (Strauss and Strauss,
994). The early replicase mediates synthesis of the negative-
tranded RNA complementary to the genomic 42S RNA. Minus
∗ Corresponding author at: Institute of Molecular and Cell Biology, University
f Tartu, Nooruse 1, 50411 Tartu, Estonia. Tel.: +372 7374881;
ax: +372 7374900.
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Open access under CC BY license.trands are used by the late replicase as templates for the syn-
hesis of new positive strand 42S RNA, and for transcription of
ubgenomic mRNAs encoding the structural proteins.
The structural genes of SFV are not required for replica-
ion and can be removed or replaced with a polylinker and/or
ith foreign gene sequences. This property forms the basis of
he SFV-based replicon vector systems (Liljestrom and Garoff,
991; Smerdou and Liljestrom, 1999). SFV-based replicon vec-
ors mediate high-level expression of heterologous proteins.
owever, as with virus, vectors cause shutdown of cellular
iosynthesis and induce apoptotic death (Glasgow et al., 1997,
998; Scallan et al., 1997). This precludes long-term foreign
ene expression, and several attempts to reduce the cytotoxicity
f alphavirus vectors have been made (Fazakerley et al., 2002;
undstrom et al., 2003, 2001; Perri et al., 2000).
The anti-apoptotic gene bcl-2 is an antagonist of the intrinsic
itochondrial pathway of apoptosis (for reviews see Ashe and
erry, 2003; Cory and Adams, 2002; Tsujimoto and Shimizu,
000). Bcl-2 can prevent release of cytochrome c from mito-
hondria, thus, precluding the apoptotic cascade (Kluck et al.,
997; Yang et al., 1997). Bcl-2 can block apoptosis induced by
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everal viruses, including influenza virus and reovirus (Nencioni
t al., 2003; Rodgers et al., 1997). Existing data on Bcl-2 in
FV- or Sindbis virus-induced apoptosis are contradictory. On
ne hand it has been shown that alphavirus-induced apoptosis of
aby hamster kidney (BHK) cells, Chinese hamster ovary cells,
at insulinoma cells and rat prostatic adenocarcinoma (AT3) cells
an be prevented by over-expression of Bcl-2 (Levine et al.,
993; Lundstrom et al., 1997; Mastrangelo et al., 2000; Scallan et
l., 1997). Similarly, a Sindbis virus expressing Bcl-2 produces
educed encephalitis in infected mice (Levine et al., 1996). That
cl-2 expression can block apoptosis, suggests involvement of
ntrinsic pathway of apoptosis. In contrast, other studies using
at embryo fibroblasts and monocyte cell lines overexpressing
cl-2 failed to detect a protective effect against alphavirus-
nduced apoptosis (Grandgirard et al., 1998; Murphy et al.,
001).
The aim of this study was to determine whether expression
f anti-apoptotic Bcl-2 directly from SFV-based replicon vec-
ors in BHK-21 cells could be used to prolong co-expression
f marker proteins from a bicistronic SFV replicon. Using the
FV1 vector system (Liljestrom and Garoff, 1991), the bcl-2
ene was placed either under the control of a duplicated SFV
ubgenomic promoter or an internal ribosome entry site (IRES).
t is possible that expression of Bcl-2 from the subgenomic pro-
oter occurs too late to prevent cell death. Expression from
n IRES element within the genomic RNA should be more
apid. We tested two different IRES elements, the Encephalomy-
carditis virus IRES (EMCV-IRES) and the crucifer-infecting
obamovirus IRES (CR-IRES). The latter is a 148-nt element,
hich precedes the CR coat protein gene and displays IRES
ctivity across all kingdoms (Dorokhov et al., 2002). Using
his novel approach we demonstrate that early Bcl-2 expression
oes not protect SFV-infected BHK-21 cells from alphavirus-
nduced translational shutdown or cell death. Moreover, our
esults indicate that SFV-induced cell death in BHK-21 cells
oes not involve the release of cytochrome c from mitochon-
ria, and most likely does not occur by the apoptotic intrinsic
athway.
. Materials and methods
.1. Plasmid construction
The BamHI-XmaI multicloning site of the pSFV1 replicon
Liljestrom and Garoff, 1991) was replaced with a BamHI, ApaI,
laI, AvrII, NruI, NsiI and XmaI multicloning site; the resulting
onstruct was designated as pSFV-PL. The spliced sequences
ncoding the mouse Bcl-2 alpha protein (locus AAA37282),
he EMCV-IRES (pIRES2-EGFP; BD Clontech) and the 148 bp
R-IRES (Ivanov et al., 1997) were amplified by PCR, cloned
nd verified by sequence analysis. Each IRES was fused to
he Bcl-2 coding sequence and cloned into NsiI-XmaI digested
SFV-PL vector; obtained constructs were designated as pSFV-
MCV-bcl2 and pSFV-CR-bcl2. To create constructs expressing
cl-2 protein from the duplicated subgenomic promoter, the
RES from pSFV-EMCV-bcl2 was replaced by an oligonu-
leotide duplex representing the minimal SFV subgenomic
0
g
f
1Fig. 1. Schematic presentation of replicon vectors.
romoter (Hertz and Huang, 1992); the resulting construct was
esignated pSFV-PR-bcl2. The d1EGFP reporter gene (BD
lontech) was amplified by PCR, sequenced and cloned into
SFV-PL, pSFV-EMCV-bcl2, pSFV-CR-bcl2 and pSFV-PR-
cl2 vectors treated with ClaI-NsiI. Resulting constructs were
esignated as pSFV-PL-d1EGFP, pSFV-d1EGFP-EMCV-bcl2,
SFV-d1EGFP-CR-bcl2 and pSFV-d1EGFP-PR-bcl2, respec-
ively (Fig. 1). Sequences and primers are available upon request.
To construct SFV replicons expressing mutated chro-
oprotein HcRed (from the reef coral Heteractis crispa),
cRed was PCR amplified (from pHcRed1-N1; BD Clon-
ech), cloned and sequenced. The sequence encoding Bcl-2
rom pSFV-d1EGFP-EMCV-bcl2, pSFV-d1EGFP-CR-bcl2 and
SFV-d1EGFP-PR-bcl2 was replaced with HcRed to give
onstructs pSFV-d1EGFP-EMCV-HcRed, pSFV-d1EGFP-CR-
cRed and pSFV-d1EGFP-PR-HcRed (Fig. 1).
To obtain constructs used for viability analysis under
uromycin selection, the sequence encoding d1EGFP from
SFV-PL-d1EGFP, pSFV-d1EGFP-EMCV-bcl2, pSFV-
1EGFP-CR-bcl2 and pSFV-d1EGFP-PR-bcl2 was replaced
y that of puromycin acetyltransferase (Pac), and constructs
ere designated pSFV-PL-Pac, pSFV-Pac-EMCV-bcl2,
SFV-Pac-CR-bcl2 and pSFV-Pac-PR-bcl2.
To generate infectious RNA, constructs were linearised by
peI digestion and in vitro transcription was carried out as pre-
iously described (Karlsson and Liljestrom, 2003).
.2. Cells and viruses
BHK-21 cells were grown in Glasgow’s Minimal Essential
edium containing 5% foetal calf serum, 0.3% tryptose phos-
hate broth, 0.1 U/ml penicillin and 0.1g/ml streptomycin.
T3-neo and AT3-bcl2 cells were grown in Roswell Park Memo-.1 U/ml penicillin and 0.1g/ml streptomycin. All cells were
rown at 37 ◦C in a 5% CO2 atmosphere. SFV4 was derived
rom the infectious cDNA clone pSP6-SFV4 (Liljestrom et al.,
991).
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.3. Transfection and collection of virus-like particles
VLPs)
BHK-21 cells were co-transfected with equal amounts of vec-
or and helper RNA (Liljestrom and Garoff, 1991). Helper RNA
ncodes the structural proteins under subgenomic promoter.
ransfected cells were grown at 28 ◦C for 72 h and the VLPs
ollected, concentrated, purified and titrated as described by
arlsson and Liljestrom (2003). Although the replicase encoded
y the replicon vector will amplify both RNAs, helper RNA is
ot packed into VLPs due to a missing packaging signal. To
etermine if any replication-proficient viruses were formed due
o the recombination between replicon vector RNA and helper
NA, batches of VLPs were tested as described by Smerdou and
iljestrom (1999). All infections with VLPs were carried out in
HK-21 cells at a multiplicity of infections 10 (moi = 10) for
h at 37 ◦C.
.4. Metabolic labelling
BHK-21 cells in 35 mm diameter plates were infected with
FV VLPs as described above. Infected cells were washed twice
ith PBS, once with methionine and cysteine free Dulbecco’s
odified Eagle Medium followed by 30 min labelling with
0Ci/ml of [35S]methionine and [35S]cysteine (RedivuePRO-
IX, Amersham Biosciences). After labelling, cells were
ashed with PBS, lysed in Laemmli buffer and analyzed by
DS-PAGE. Gels were dried under vacuum and exposed to film.
.5. Immunoblot analysis
BHK-21 cells were infected and samples collected as
escribed above. After SDS-PAGE, proteins were transferred
o a nitrocellulose membrane, probed with rabbit polyclonal
ntisera against SFV nsP1, EGFP (in-house), HcRed (Clon-
ech), with a mouse monoclonal antibody against Bcl-2 (Santa
ruz Biotechnology, Inc.) or with a mouse monoclonal anti-
ody against beta-actin (C4) (Cruz Biotechnology, Inc.) and
isualized by ECL immunoblot detection kit (Amersham Life
cience).
.6. Analysis of bicistronic SFV vector cytotoxicity in
HK-21 cells
Cytotoxicity of SFV vectors was analyzed as described by
armashova et al., 2006. Replicon RNA was obtained from
SFV-PL-Pac, pSFV-Pac-EMCV-bcl2, pSFV-Pac-CR-bcl2 and
SFV-Pac-PR-bcl2. 106 BHK-21 cells were electroporated with
g of RNA. Cells were seeded into wells (growth area 2.0 cm2
er well; Cellstar, Greiner bio-one plates) and selected with
uromycin (10g/ml) from 6 h post-transfection. Viable adher-
nt cells were determined at 6, 24, 48 and 72 h post-transfection
sing Trypan blue (Flow Laboratories).The viability of infected cells was also analyzed by WST-1
ssay (Roche). The assay is based on the reduction of WST-1
o a water-soluble formazan dye by viable cells. BHK-21 cells
ere seeded in 96-well plates (7 × 103 cells/well), grown for
i
B
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(rch 131 (2008) 54–64
8 h and infected with VLPs containing recombinant replicons
t moi = 10. Control cells were mock-infected. Infected cells
ere analyzed 6, 24 or 48 h post-infection (p.i.) by adding 10l
f WST-1 to each well, followed by incubating the plate for
h and measuring the change in color intensity at 450 nm in a
icroplate reader.
.7. Immunoﬂuorescence microscopy
Cells were grown on cover slips and infected for selected
imes, mock-infected cells were used as controls. Cells were
ashed with PBS, fixed with 4% paraformaldehyde for 10 min
t room temperature and permeabilized with cold methanol for
min at −20 ◦C. Cells were then washed with PBS, blocked in
he 3% BSA-PBS and incubated for 1 h with primary antibody
mouse anti-cytochrome c monoclonal antibody (BD Pharmin-
en) or rabbit polyclonal antibody against SFV nsP1). Then
he cells were washed again with PBS and incubated with
AlexaFluor 568 (Invitrogen) or Cy3 conjugated secondary
ntibody for 1 h, washed three times with PBS and air-dried.
taurosporine (final concentration 0.5M) was added to mock-
nfected cells 1–2 h before fixing to induce release of cytochrome
from mitochondria. Samples were analyzed on an Olym-
us U-RFL-TX microscope or a Bio-Rad MRC-1024 confocal
icroscope.
.8. Analysis of the viability of AT3 cells infected with SFV
LPs
3 × 106 AT3-neo or AT3-bcl2 cells were infected with VLPs
n serum-free RPMI1640 media supplemented with 0.2% BSA.
he amount of VLPs used for infections corresponded to a
oi = 20 for BHK-21 cells. At 12 h p.i., EGFP positive cells were
eparated using a BD FACSAria cell sorter; EGFP-positive cells
ere seeded in 24-well plates. Viable cells were determined at
4 and 48 h p.i. using Trypan blue (Flow Laboratories).
. Results
.1. Expression of d1EGFP and Bcl-2 using bicistronic
FV vectors
To study the expression of foreign proteins using the
icistronic replicons, BHK-21 cells were infected with
FV-d1EGFP-CR-bcl2, SFV-d1EGFP-EMCV-bcl2 and SFV-
1EGFP-PR-bcl2 VLPs and in addition, with monocistronic
FV-PL-d1EGFP VLPs. Samples were collected at 2, 4, 6,
, 12 and 24 h p.i. and analyzed by immunobloting. Expres-
ion of SFV nsP1 was generally detectable by 2 h p.i. and
ncreased up to 8–12 h p.i. (Fig. 2a–e). The amount of nsP1
as approximately equal for all bicistronic vectors (Fig. 2b–d).
xpression of d1EGFP was also detectable by 2-4 h post-
nfection (Fig. 2a–d) and was highest in SFV-PL-d1EGFP
nfected cells (Fig. 2a). Major differences were observed with
cl-2 expression, which was detected on immunoblots as two
ands (Fig. 2b–d). Bcl-2 expression was strongest and earliest
2 h p.i.) in SFV-d1EGFP-EMCV-bcl2 infected cells (Fig. 2c). In
K. Kiiver et al. / Virus Research 131 (2008) 54–64 57
Fig. 2. Expression of SFV nsP1, d1EGFP, Bcl-2 and HcRed proteins in infected BHK-21 cells at 2, 4, 6, 8, 12 and 24 h p.i. Infected cells (9 × 105 cells/well) were
collected, lysed and equal amounts of lysates analyzed by immunoblotting; beta-actin was used for normalization. Lysates of cells infected with SFV-PL-d1EGFP,
SFV-d1EGFP-CR-bcl2, SFV-d1EGFP-EMCV-bcl2, SFV-d1EGFP-PR-bcl2 and SFV-d1EGFP-EMCV-HcRed VLPs are shown in panels a–e, respectively. Time of
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cnfection is shown at the top of each lane. Mock—mock-infected BHK-21 cells;
ositions of molecular mass standards. Experiments were repeated twice, with
ells infected with SFV-d1EGFP-CR-bcl2 (Fig. 2b), expression
f Bcl-2 was detected 4 h p.i. Expression of Bcl-2 was also found
n cells infected with SFV-d1EGFP-PR-bcl2 (Fig. 2d) although
evels were lower compared to IRES containing constructs.
To assess the ability of the bicistronic vectors to express
roteins in general, Bcl-2 sequences were replaced with
on-cytotoxic HcRed. The resulting replicons SFV-d1EGFP-
MCV-HcRed, SFV-d1EGFP-CR-HcRed and pSFV-d1EGFP-
R-HcRed were used to infect BHK-21 cells. There was no
ignificant difference in the expression of nsP1 and d1EGFP
roteins between bicistronic vectors also expressing HcRed or
cl-2 (Fig. 2e for SFV-d1EGFP-EMCV-HcRed, data not shown
or SFV-d1EGFP-CR-HcRed and pSFV-d1EGFP-PR-HcRed).
xpression of HcRed was strongest for SFV-d1EGFP-EMCV-
cRed (detectable by Western blotting by 4 h p.i.; Fig. 2e).
his is in agreement with previous observations suggesting that
he highest expression levels of the second target proteins are
t
Bt the left indicate positions of corresponding proteins; lanes at the right indicate
r results.
chieved with SFV-d1EGFP-EMCV vectors. The apparent delay
n detection of protein expression (2 h p.i. for Bcl-2 versus 4 h
.i. for HcRed) is most likely due to the quality of the HcRed
ntibody (Clontech).
Thus, vectors containing IRES elements expressed Bcl-2
arlier and to higher levels. Presence of a duplicated subge-
omic promoter or IRES element following the Bcl-2 encoding
equence did not have any major effect on the time-course of
nfection, however, differences in expression levels of the first
arker protein, d1EGFP, were observed.
.2. Effects of infections by recombinant SFV VLPs on host
ell protein synthesisMetabolic labelling was used to study the effects of infec-
ion by SFV VLPs on host cell protein synthesis. Infected
HK-21 cells were pulse labelled at 2, 4, 6, 8, 12 and 24 h
58 K. Kiiver et al. / Virus Research 131 (2008) 54–64
Fig. 3. Effects of VLP infection on the host cell protein synthesis. BHK-21 cells (9 × 105 cells/well) either mock-infected (A) or infected with SFV-PL-d1EGFP
(B), SFV-d1EGFP-CR-bcl2 (C), SFV-d1EGFP-EMCV-bcl2 (D) or SFV-d1EGFP-PR-bcl2 (E) VLPs were metabolically labelled at 2, 4, 6, 8, 12 and 24 h p.i. Equal
a radiography. Time of infection is shown at the top of each lane. Positions of molecular
m and Bcl-2 are indicated at the right. Arrow on panel D positions Bcl-2 expressed by
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Fig. 4. Analysis of survival (a) and viability (b) of cells infected with SFVmounts of collected cell lysates were analyzed by SDS-PAGE, followed by auto
ass standards are indicated on the left, positions of SFV nsP1–nsP4, d1EGFP
FV-d1EGFP-EMCV-bcl2.
.i. In contrast to mock-infected cells, where protein synthesis
s ongoing (Fig. 3A), translation in infected cells was rapidly
nhibited (Fig. 3B–E). Shutdown of host protein synthesis was
etected as early as 4 h p.i. (Fig. 3B–E). High-level and con-
inuous expression of Bcl-2 was visible in cells infected with
FV-d1EGFP-EMCV-bcl2 (Fig. 3D). In cells infected with other
icistronic vectors, expression of Bcl-2 could only be detected
y Western blot (Fig. 2b–d). These results indicate that high-
evel, continuous expression of Bcl-2 from a bicistronic replicon
ector does not protect against shut-off of host cell protein
ynthesis.
.3. Survival of cells infected with Bcl-2 expressing
icistronic replicons
It has been shown that similar to wild-type virus, alphavirus
ased replicon vectors induce apoptotic death of infected verte-
rate cells (Glasgow et al., 1997, 1998; Scallan et al., 1997)
nd that over-expression of Bcl-2 can protect cells against
lphavirus-induced apoptosis (Lundstrom et al., 1997; Scallan
t al., 1997).
To study the effect of Bcl-2 expression from bicistronic
ectors on cell death, BHK-21 cells were transfected
ith SFV-PL-Pac, SFV-Pac-EMCV-bcl2, SFV-Pac-CR-bcl2
nd SFV-Pac-PR-bcl2 replicons or mock-transfected, and
uromycin selection was applied 6 h post-transfection. Almost
ll mock-transfected cells died within 24 h of adding puromycin
Fig. 4a). The transfected cells survived longer and the percent-
ge of viable adherent cells was found to be similar at the selected
ime points (Fig. 4a). Most of the transfected cells were dead
replicons expressing Bcl-2. (a) Percentages of viable adherent BHK-21 cells at
6, 24, 48 and 72 h p.i. are shown. Puromycin selection was applied at the 6 h
post-transfection. (b) Measuring cell viability by WST-1 assay at 6, 24 and 48 h
p.i. Absorbance at 450 nm was measured 1 h after adding WST-1 reagent. Error
bars represent standard deviation.
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days post-transfection regardless of the replicon. Thus, our
esults demonstrate that high-level expression of Bcl-2 does not
rotect BHK-21 cells against SFV induced death. Similar results
ere also obtained when Annexin-V PE conjugate or propidium
odide were used to label apoptotic and necrotic cells (data not
hown).
The WST-1 assay, used to analyze cell viability, mea-
ures mitochondrial activity in cells. Results obtained with
his assay were similar to cell survival experiments: expres-
ion of Bcl-2 from bicistronic vectors (SFV-d1EGFP-CR-bcl2,
FV-d1EGFP-EMCV-bcl2 or SFV-d1EGFP-PR-bcl2) did not
rovide any protective effect (Fig. 4b). In fact, viability of cells
nfected with bicistronic replicons at 48 h p.i. was reduced, com-
ared to cells infected with SFV-PL-d1EGFP (Fig. 4b). Infection
ith SFV-d1EGFP-EMCV-bcl2 caused the most important
eduction in cell viability, which is in accordance with our pre-
ious data. (Fig. 4a). This tendency was also seen when cells
nfected with SFV-d1EGFP-EMCV-HcRed, SFV-d1EGFP-CR-
cRed and SFV-d1EGFP-PR-HcRed VLPs were analyzed by
ST-1 assay (data not shown), indicating that not Bcl-2 expres-
ion, but rather the second gene expression unit (especially
MCV-IRES) is responsible for this effect. Taken together,
ur results suggest that Bcl-2 expression does not have a
etectable effect on the viability of SFV-infected BHK-21
ells.
u
o
f
p
ig. 5. Sub-cellular localization of cytochrome c in BHK-21 cells. (A) Localization of
ells treated with staurosporine. BHK-21 cells infected with SFV-PL-d1EGFP VLP
ytochrome c was analyzed (D). d1EGFP fluorescence and cytochrome c localizationrch 131 (2008) 54–64 59
.4. SFV infection does not induce release of cytochrome c
rom mitochondria
The anti-apoptotic effect of Bcl-2 is connected to its ability to
revent the release of cytochrome c from mitochondria (Kluck et
l., 1997; Yang et al., 1997). Apoptosis induced by death recep-
ors or by ER stress bypasses this mitochondrial pathway and is,
herefore, relatively insensitive to protection by Bcl-2 (Scaffidi
t al., 1998). The finding that high-levels of Bcl-2 expression did
ot have a protective effect against SFV induced death suggests
hat apoptosis in SFV-infected BHK-21 cells may not involve the
itochondrial pathway. To determine whether the mitochondrial
athway is activated in SFV-infected BHK cells, localization of
ytochrome c was visualized by immunofluorescence in BHK-
1 cells infected with the SFV-PL-d1EGFP 4 and 24 h p.i.
ocalization of cytochrome c in mock-infected BHK-21 cells
as mitochondrial as evidenced by dotty localization (Fig. 5A).
n cells, treated with the non-selective protein kinase inhibitor
taurosporine, cytochrome c staining was diffuse, demonstrating
ts release from mitochondria (Fig. 5B). In cells infected with
FV-PL-d1EGFP, the cytochrome c staining maintained a gran-
lar pattern 4 h p.i. (Fig. 5C and D), indicating that when shut-off
f cellular gene expression starts cytochrome c was not released
rom mitochondria. Furthermore, the cytochrome c localization
attern was unchanged even at 24 h p.i. (Fig. 5E and F). We
cytochrome c in mock-infected BHK-21 cells or (B) in mock-infected BHK-21
s were visualized at 4 h p.i. by d1EGFP fluorescence (C) and localization of
24 h p.i are shown on panels E and F, respectively.
60 K. Kiiver et al. / Virus Research 131 (2008) 54–64
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Tig. 6. Sub-cellular localization of cytochrome c in BHK-21 cells infected wit
.i., respectively. (B, D, F) cytochrome c localization 4, 12 and 24 h p.i., respec
onclude that induction of cell death in SFV replicon-infected
HK-21 cells does not involve the release of mitochondrial
ytochrome c. This result is consistent with the absence of a
rotective effect of Bcl-2.
SFV replicons lack the coding sequences for structural pro-
eins. To analyze the role of the structural proteins in the
elease of cytochrome c from mitochondria, BHK-21 cells were
nfected with SFV4 (moi = 1) and localization of cytochrome
was determined at 4, 12 and 24 h p.i. By 4 h p.i. infected
ells did not release cytochrome c (Fig. 6A and B). At 12
nd 24 h p.i. detection of cytochrome c became more difficult
ue to extensive cytopathic effects. This includes cell round-
ng and re-localization of mitochondria into the perinuclear
egion (Fig. 6C–F); all these effects were more extensive than in
FV-PL-d1EGFP infected cells (Fig. 5). Nevertheless, the local-
zation pattern of cytochrome c remained dotty indicating that
ts mitochondrial localization was preserved (Fig. 6C–F). Taken
ogether, these results indicate that for both replicon vector and
FV4 infection, BHK-21 cells do not release cytochrome c from
he mitochondria.
.5. Bcl-2 expression does not protect SFV-infected
T3-neo cells against cell death
To analyze whether the absence of cytochrome c release and
ack of the protection against SFV induced cell death are specific
i
i
r
a4 virus particles (moi = 1). (A, C, E) nsP1 protein localization 4, 12 and 24 h
.
o BHK-21 cells, two lines of AT3 cells, AT3-neo (Cepko et
l., 1984) and AT3-Bcl2 (Levine et al., 1993) cells were also
haracterized.
Firstly, AT3-neo cells were infected with SFV4 and
ytochrome c distribution was determined. Infected AT3-neo
ells showed extensive virus-induced cytopathic effects but
s with BHK-21 cells no detectable release of cytochrome c
Fig. 7). Similarly, no detectable release of cytochrome c was
bserved in AT3-neo or AT3-bcl2 cells infected with SFV-
1EGFP-EMCV-bcl2 (Fig. 8A–D and I–L) or SFV-PL-d1EGFP
LPs (Fig. 8E–H and M–P). Therefore, we conclude that the
nability of SFV to induce cytochrome c release from mitochon-
ria was not a BHK-21 cell line-restricted phenomenon.
Secondly, the viability of the AT3-neo and AT3-bcl2 cells,
nfected with SFV VLPs was analyzed. It should be noted that
e were unable to obtain highly efficient infection of the AT3-
eo and especially the AT3-bcl2 cells by use of the SFV VLPs.
ypically, up to 20% of AT3-neo and 10% of AT3-bcl2 cells were
nfected when the amount of VLPs, corresponding to moi = 20
n BHK-21 cells, was used for infection; using larger amounts
f VLPs did not result in higher percentages of infected cells.
hus, we conclude that AT3 cells are not as susceptible for SFVnfection as BHK-21 cells and sorting of EGFP positive (i.e.
nfected) cells before the viability analysis was required. This
evealed that, in the case of AT3-neo cells, expression of Bcl-2 by
ny SFV replicon vector did not provide any protective effect
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hown on panels C and E, respectively. Localization of nsP1 at 4 and 24 h p.i. is
nd almost all infected cells were dead by 48 h p.i. (Fig. 9a).
hus, the results were highly similar to those obtained in BHK-
1 cells. In contrast, we found that almost all AT3-bcl2 cells,
nfected with SFV VLPs, were viable at 24 h p.i. and over the
ext 24 h numbers of viable cells rapidly increased in all samples.
his indicates efficient cell division (Fig. 9b). Since cell sorting
uled out the possibility of non-infected cells being present in
nalyzed samples, we concluded that AT3-bcl2 cells, infected
ith SFV replicons were either able to recover from infection or,
lternatively, established a persistent infection. Our observation
hat surviving AT3-bcl2 cells rapidly lost EGFP fluorescence
avours the first option. Expression of Bcl-2 by SFV replicons
ad little or no effect on survival and subsequent division of
nfected AT3-bcl2 cells. All results taken together we conclude
hat not bcl-2 expression as such but some other property of
T3-bcl2 cells is likely responsible for this phenomenon.
. Discussion
Previously published data on mechanisms of alphavirus-
nduced cell death are controversial (Glasgow et al., 1997;
riffin, 2005; Li and Stollar, 2004). On the one hand, induc-
ion of apoptotic cell death via the death receptor pathway
as been suggested (Li and Stollar, 2004; Nava et al., 1998);
n the other hand, it has been shown that over-expression of
c
a
s
otochrome c in mock-infected AT3-neo cells or in mock-infected AT3-neo cells
cytochrome c in AT3-neo cells infected with SFV4 (moi = 1) 4 and 24 h p.i. is
n in panels D and F, respectively.
he anti-apoptotic Bcl-2 can protect against alphavirus-induced
poptosis and pathogenesis (Levine et al., 1993; Lundstrom et
l., 1997; Mastrangelo et al., 2000; Scallan et al., 1997). How-
ver, in these studies different alphaviruses, strains, cell lines and
xperimental systems were used. It is possible that mechanisms,
y which cell death is induced may differ between viruses, cells
tc.
In this study, shut-off of cellular translation and cell death
n SFV-infected BHK-21 cells were studied using a novel
icistronic replicon vector system. This avoids transient or stable
xpression of Bcl-2 in host cells. In transiently transfected cells,
ell metabolism can be seriously altered by the transfection pro-
edure (Lepik et al., 2003). Stable expression of Bcl-2, known
o have oncogenic properties (Reed, 1994; Reed et al., 1991),
ay lead to adaptation of the cell, which in turn might affect
irus replication and the outcome of infection. It is also impor-
ant to mention that both transient and stable cellular expression
re mediated by cellular RNA polymerase II and are, therefore,
ubjected to the alphavirus-induced transcriptional shutdown,
hich starts early in infection.
In this study, Bcl-2 was expressed using novel vectorsontaining IRES elements. The use of IRESs has significant
dvantages over other systems. The first important advantage, as
hown by our results (Fig. 2), is that IRES-mediated expression
f Bcl-2 can take place directly from incoming genomic RNA.
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, G, H, K, L, O and P). d1EGFP (green) was detected by auto-fluorescence an
n contrast, expression from the subgenomic promoter requires
eplication and is activated later on in infection. Early expres-
ion of Bcl-2 may be crucial since it is not known when and how
ell death is induced. It is possible that expression of Bcl-2 from
he subgenomic promoter is too late to protect from cell death.
nother important advantage of IRES-mediated expression is
he level of expression, which is significantly higher than from
he minimal subgenomic promoter (Fig. 2). It is also important
o mention that at least for the EMCV-IRES, synthesis of Bcl-2
as resistant to inhibition of cellular translation (Fig. 3D).
Detection of Bcl-2 protein by immunoblotting in BHK-
1 cells infected with VLPs of SFV1 vectors harboring bcl-2
a
h
o
t3-bcl2 cells (panels I–P). Cells were infected with SFV-d1EGFP-EMCV-bcl2
nalyzed either 6 h p.i. (panels A, B, E, F, I, J, M and N) or 24 h p.i. (panels C,
chrome c (red) by indirect immunofluorescence.
evealed a lower molecular band, which increased in intensity
roportional to Bcl-2 expression. This is presumably protein
xpressed from an internal initiation site (Tsujimoto and Croce,
986). The truncated protein could also be the product of Bcl-2
leavage by endogenous caspase-3, resulting in curtailed Bcl-
with proapoptotic activity (Cheng et al., 1997; Kirsch et al.,
999). The latter localizes to mitochondria and causes the release
f cytochrome c, thus, promoting further caspase activation
s a part of a positive feedback loop (Kirsch et al., 1999). It
as been shown that alphaviruses induce apoptosis in Bcl-2-
verexpressing cells by caspase-mediated proteolytic inactiva-
ion of Bcl-2 (Grandgirard et al., 1998). Viral capsid protein was
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uggested to trigger activation of the cell death machinery. How-
ver, in this study neither release of cytochrome c nor increase
n the proportion of truncated product due to feedback loop
ction was observed. Infection of cells with VLPs eliminated
he possibility that capsid protein alone triggers apoptosis.
Simultaneous expression of two target proteins was achieved
ith all the bicistronic SFV expression vectors constructed in
his study. The expression level of d1EGFP was slightly reduced
or bicistronic vectors, compared to the monocistronic SFV-PL-
1EGFP, independent of the nature of the second gene (bcl-2
r HcRed) (Fig. 2). Interference between the native subgenomic
romoter and the duplicated promoter or IRES element may
ave influenced expression from the first promoter. It is also
ossible that presence of the IRES elements had some effect on
eplication. However, infectivity of bicistronic vectors was not
ltered. Taken together, these results indicate that different IRES
lements can be used to construct novel and efficient bicistronic
FV vectors.
In this study, we show that early and high-level of Bcl-2
xpression, achieved with bicistronic SFV replicon vectors, did
ot have a detectable effect on host protein synthesis shut-off
Fig. 3) or cell death (Fig. 4). This cannot be attributed to the
elayed expression of bcl-2 since its high expression levels were
bserved at early time points (Fig. 2). These findings are coher-
nt with our data suggesting that infection of BHK-21 cells
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ith SFV replicons or with SFV4 does not cause the release
f cytochrome c from mitochondria (Figs. 5 and 6). This effect
as not restricted to BHK-21 cells since similar results were also
btained for AT3-neo (Figs. 7 and 8) and AT3-bcl2 (Fig. 8) cells.
he release of cytochrome c in SFV-infected BHK-21 or AT3-
eo cells did not even occur at late time points. This explains the
ack of protective effect by Bcl-2 expression against cell death
n infected cells, as observed by us.
At the same time, the mechanism of cell death in infected cells
emains unknown. We can rule out that binding of virions to the
ellular receptor and/or virus internalisation have crucial roles,
ince induction of cell death does not depend on whether the cells
re infected with virus or transfected by infectious transcripts.
t seems most likely that cell death is induced by some non-
itochondrial pathway. This is consistent with previous data,
hich suggested that apoptosis in alphavirus infected cells uses
he death receptor pathway (Nava et al., 1998; Li and Stollar,
004). However, our findings do not exclude the possibility that
ell death in SFV-infected BHK-21 cells may be triggered by
he ER pathway.
A delay of cell death in SFV-infected AT3 cell line expressing
cl-2 has been reported (Scallan et al., 1997). Our results confirm
hat the AT3-bcl2 cell line is remarkably resistant to infection
y SFV VLPs. However, our data is more coherent with the
ypothesis that these cells are not just delaying cell death but
re also capable to recover from SFV infection. The finding
hat Bcl-2 expression by SFV replicons did not have any effect
n the survival of AT3-neo cells suggests that resistance of the
T3-bcl2 cells to the SFV infection most likely represents an
ndirect effect of Bcl-2. The Bcl-2 gene is potent oncogene and
ts constitutive expression significantly changes cell cycle and
ene expression. It is indeed evident from data presented in Fig. 9
hat AT3-bcl2 cells grow much more rapidly than AT3-neo cells.
t could be hypothesized that constitutive expression of Bcl-
in AT3-bcl2 cells may have resulted in changes protecting
ells from virus infection. The most likely candidates for roles
f these factors may be the components of the innate immune
ystem and/or host factor(s) like rat zinc-finger antiviral protein,
hich provides resistance against alphavirus infection (Bick et
l., 2003).
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